1-3 of 3
Joyce Bass, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Expansion Study Of Vorinostat In Combination With Idarubicin and Cytarabine For Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations

Koichi Takahashi, MD, Elias Jabbour, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MBBS, Jorge E. Cortes, MD, Tapan Kadia, Susan O'Brien, MD, Deborah A. Thomas, MD, Stefan Faderl, MD, Joyce Bass, RN, William G. Wierda, MD, PhD, Naval Daver, MD, Courtney D. DiNardo, MD, Sherry Pierce, Mark Brandt, Hagop M Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2013) 122 (21): 2684.
https://doi.org/10.1182/blood.V122.21.2684.2684
Published: 2013
Journal Articles

Dynamics of Molecular Response in Patients (pts) with Acute Myeloid Leukemia (AML) Withy Core Binding Factor (CBF) Abnormalities Treated with High-Dose Cytarabine Regimen

Elias J. Jabbour, MD, Hagop M. Kantarjian, MD, Yin Cameron, MD, PhD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Hady Ghanem, MD, Tapan M. Kadia, M.D., Stefan Faderl, MD, Susan O'Brien, M.D., Michael S Mathisen, PharmD, Mark Brandt, BS, Naveen Pemmaraju, M.D., Deborah A. Thomas, MD, Joyce Bass, RN, Gautam Borthakur
Journal: Blood
Blood (2012) 120 (21): 3609.
https://doi.org/10.1182/blood.V120.21.3609.3609
Published: 2012
Journal Articles

Clinical and Molecular Response in Core Binding Factor Acute Myelogenous Leukemia with Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin.

Gautam Borthakur, MD, Stefan Faderl, MD, Srdan Verstovsek, MD, PhD, Dan Jones, MD, PhD, Varsha Gandhi, PhD, Zeev Estrov, MD, Susan O'Brien, M.D., Farhad Ravandi, MD, Joyce Bass, RN, Mark Brandt, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2056.
https://doi.org/10.1182/blood.V114.22.2056.2056
Published: 2009